MAG and chronic inflammatory demyelinating polyradiculoneuropathy: CIDP responds to immunoglobulin, corticosteroids, and plasma exchange, whereas anti-MAG antibody neuropathy generally responds better to anti-CD20 monoclonal antibodies such as rituximab [3▪,33▪▪].